Brain Tumor Treatments: South Dakota

Sponsored By

Please Click On The Above Banner For More Details

[Click HERE to print this page!]

Search Term: South Dakota
Please scroll down to see the matching trials.

  (0.8351) Brain Tumor Treatments: South Dakota
  (0.7742) Untitled Document
  (0.7742) Brain Tumor Activism
  (0.7742) Letter Writing Wizard
  (0.7742) Brain Tumor Activism

Sorry - There were no pages found that contain that search phrase.


	Treatment	Location	Last Updated

Details	Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma	Rapid City, SD USA	04/11/2008

Details	Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study)	Sioux Falls, SD USA	10/12/2006

Details	Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma	Sioux Falls, SD USA	06/26/2006

Details	Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma	Sioux Falls, SD USA	11/27/2005

Details	Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma	Rapid City, SD USA	11/27/2005

Details	Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma	Sioux Falls, SD USA	11/27/2005

Details	Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma	Sioux Falls, SD USA	11/27/2005

Details	Phase II Study of Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiotherapy With or Without Peripheral Blood Stem Cell Rescue in Patients With Intracranial Non-Germinomatous Germ Cell Tumors	Sioux Falls, SD USA	11/26/2005

Details	A Phase II Study of HLA-Matched Peripheral Blood Stem Cell Transplantation for Metastatic Renal Cell Carcinoma as Adoptive Allogeneic Immunotherapy	Sioux Falls, SD USA	11/06/2005